Market Tracker

08/18 5:16pm ET

Endo International PLC (NASDAQ:ENDP)

8.72
Delayed Data
As of Aug 18
 +0.09 / +1.04%
Today’s Change
7.41
Today|||52-Week Range
24.93
-47.06%
Year-to-Date
Endo International (ENDP) Jumps: Stock Rises 6.9%
Aug 17 / Zacks.com - Paid Partner Content
Endo (ENDP) Q2 Earnings Beat Estimates, 2017 Guidance Cut
Aug 08 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Q2 Loss Wider than Expected, Stock Falls
Aug 10 / Zacks.com - Paid Partner Content
What's in Store for BioDelivery (BDSI) This Earnings Season?
Aug 07 / Zacks.com - Paid Partner Content
Endo (ENDP) Beats Q2 Earnings & Sales, 2017 Guidance Lowered
Aug 08 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close8.63
Today’s open8.59
Day’s range8.56 - 8.88
Volume5,294,100
Average volume (3 months)6,662,729
Market cap$1.9B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-96.37%
Earnings growth (this year)-25.41%
Earnings growth (next 5 years)-7.30%
Revenue growth (last year)+22.69%
P/E ratioNM
Price/Sales0.91
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-1.75-3.19%
FOLDAmicus Therapeutics ...+0.22+1.79%
PRTAProthena Corporation...-0.64-1.16%
LOXOLoxo Oncology Inc+0.60+0.84%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.67
Annual revenue (last year)$4.0B
Annual profit (last year)-$3.3B
Net profit margin-80.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts